Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles

References

• Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94:1840 - 7; PMID: 10477712
   PubMed Web of Science ®Google Scholar
• Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94:1848 - 54; PMID: 10477713
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Johnson A, Eriksson I, Söderberg O, Karlsson K, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003; 101:4952 - 7; http://dx.doi.org/10.1182/blood-2002-11-3485; PMID: 12586612
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004; 104:2879 - 85; http://dx.doi.org/10.1182/blood-2004-01-0132; PMID: 15217826
   PubMed Web of Science ®Google Scholar
• Messmer BT, Albesiano E, Efremov DG, Ghiotto F, Allen SL, Kolitz J, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004; 200:519 - 25; http://dx.doi.org/10.1084/jem.20040544; PMID: 15314077
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 2007; 109:259 - 70; http://dx.doi.org/10.1182/blood-2006-03-012948; PMID: 16985177
   PubMed Web of Science ®Google Scholar
• Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008; 111:1524 - 33; http://dx.doi.org/10.1182/blood-2007-07-099564; PMID: 17959859
   PubMed Web of Science ®Google Scholar
• Darzentas N, Hadzidimitriou A, Murray F, Hatzi K, Josefsson P, Laoutaris N, et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 2010; 24:125 - 32; http://dx.doi.org/10.1038/leu.2009.186; PMID: 19759557
   PubMed Web of Science ®Google Scholar
• Agathangelidis A, Darzentas N, Hadzidimitriou A, Brochet X, Murray F, Yan XJ, et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012; 119:4467 - 75; http://dx.doi.org/10.1182/blood-2011-11-393694; PMID: 22415752
   PubMed Web of Science ®Google Scholar
• Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G, et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105:1678 - 85; http://dx.doi.org/10.1182/blood-2004-07-2606; PMID: 15466924
   PubMed Web of Science ®Google Scholar
• Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009; 144:492 - 506; http://dx.doi.org/10.1111/j.1365-2141.2008.07469.x; PMID: 19036101
   PubMed Web of Science ®Google Scholar
• Thorsélius M, Kröber A, Murray F, Thunberg U, Tobin G, Bühler A, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. Blood 2006; 107:2889 - 94; http://dx.doi.org/10.1182/blood-2005-06-2227; PMID: 16317103
   PubMed Web of Science ®Google Scholar
• Marincevic M, Mansouri M, Kanduri M, Isaksson A, Göransson H, Smedby KE, et al. Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Haematologica 2010; 95:2072 - 9; http://dx.doi.org/10.3324/haematol.2010.028639; PMID: 20801898
   PubMed Web of Science ®Google Scholar
• Fält S, Merup M, Tobin G, Thunberg U, Gahrton G, Rosenquist R, et al. Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. Blood 2005; 106:681 - 9; http://dx.doi.org/10.1182/blood-2004-10-4073; PMID: 15817677
   PubMed Web of Science ®Google Scholar
• Corcoran M, Parker A, Orchard J, Davis Z, Wirtz M, Schmitz OJ, et al. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005; 90:1078 - 88; PMID: 16079107
   PubMed Web of Science ®Google Scholar
• Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC, et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J Clin Oncol 2005; 23:3877 - 85; http://dx.doi.org/10.1200/JCO.2005.02.196; PMID: 15809452
   PubMed Web of Science ®Google Scholar
• Strathdee G, Sim A, Parker A, Oscier D, Brown R. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 2006; 20:1326 - 9; http://dx.doi.org/10.1038/sj.leu.2404254; PMID: 16688227
   PubMed Web of Science ®Google Scholar
• Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007; 129:879 - 90; http://dx.doi.org/10.1016/j.cell.2007.03.043; PMID: 17540169
   PubMed Web of Science ®Google Scholar
• Kanduri M, Cahill N, Göransson H, Enström C, Ryan F, Isaksson A, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010; 115:296 - 305; http://dx.doi.org/10.1182/blood-2009-07-232868; PMID: 19897574
   PubMed Web of Science ®Google Scholar
• Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A, et al. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients. Haematologica 2011; 96:1644 - 52; http://dx.doi.org/10.3324/haematol.2011.044792; PMID: 21750087
   PubMed Web of Science ®Google Scholar
• Ntoufa S, Vardi A, Papakonstantinou N, Anagnostopoulos A, Aleporou-Marinou V, Belessi C, et al. Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin Receptors. Molecular medicine (Cambridge, Mass 2012.
   Google Scholar
• Das PM, Singal R. DNA methylation and cancer. J Clin Oncol 2004; 22:4632 - 42; http://dx.doi.org/10.1200/JCO.2004.07.151; PMID: 15542813
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6:597 - 610; http://dx.doi.org/10.1038/nrg1655; PMID: 16136652
   PubMed Web of Science ®Google Scholar
• Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2012; In press http://dx.doi.org/10.1038/leu.2012.245; PMID: 22922567
   PubMed Web of Science ®Google Scholar
• Kulis M, Heath S, Bibikova M, Queirós AC, Navarro A, Clot G, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 2012; 44:1236 - 42; http://dx.doi.org/10.1038/ng.2443; PMID: 23064414
   PubMed Web of Science ®Google Scholar
• Athanasiadou A, Stamatopoulos K, Gaitatzi M, Stavroyianni N, Fassas A, Anagnostopoulos A. Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins. Haematologica 2008; 93:473 - 4; http://dx.doi.org/10.3324/haematol.11872; PMID: 18310544
   PubMed Web of Science ®Google Scholar
• Marincevic M, Cahill N, Gunnarsson R, Isaksson A, Mansouri M, Göransson H, et al. High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with ‘stereotyped’ IGHV3-21 and IGHV4-34 B-cell receptors. Haematologica 2010; 95:1519 - 25; http://dx.doi.org/10.3324/haematol.2009.021014; PMID: 20421269
   PubMed Web of Science ®Google Scholar
• Chu CC, Catera R, Zhang L, Didier S, Agagnina BM, Damle RN, et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 2010; 115:3907 - 15; http://dx.doi.org/10.1182/blood-2009-09-244251; PMID: 20110421
   PubMed Web of Science ®Google Scholar
• Binder M, Léchenne B, Ummanni R, Scharf C, Balabanov S, Trusch M, et al. Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells. PLoS One 2010; 5:e15992; http://dx.doi.org/10.1371/journal.pone.0015992; PMID: 21209908
   PubMed Web of Science ®Google Scholar
• Papakonstantinou N, Ntoufa S, Papadopoulos G, Hatzigeorgiou A, Anagnostopoulos A, Chlichlia A, et al. Distinct profiles of miRNAs modulating immune signalling pathways in different subsets of chronic lymphocytic Leukemia. EHA. Amsterdam, 2012.
   Google Scholar
• Peach RJ, Bajorath J, Naemura J, Leytze G, Greene J, Aruffo A, et al. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J Biol Chem 1995; 270:21181 - 7; http://dx.doi.org/10.1074/jbc.270.36.21181; PMID: 7545666
   PubMed Web of Science ®Google Scholar
• Van den Hove LE, Van Gool SW, Vandenberghe P, Bakkus M, Thielemans K, Boogaerts MA, et al. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 1997; 11:572 - 80; http://dx.doi.org/10.1038/sj.leu.2400598; PMID: 9096698
   PubMed Web of Science ®Google Scholar
• Romano C, De Fanis U, Sellitto A, Dalla Mora L, Chiurazzi F, Giunta R, et al. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells. Leuk Lymphoma 2003; 44:1963 - 71; http://dx.doi.org/10.1080/1042819031000111026; PMID: 14738151
   PubMed Web of Science ®Google Scholar
• Sutton LA, Kostareli E, Hadzidimitriou A, Darzentas N, Tsaftaris A, Anagnostopoulos A, et al. Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood 2009; 114:4460 - 8; http://dx.doi.org/10.1182/blood-2009-05-221309; PMID: 19713457
   PubMed Web of Science ®Google Scholar
• Kostareli E, Sutton LA, Hadzidimitriou A, Darzentas N, Kouvatsi A, Tsaftaris A, et al. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution. Leukemia 2010; 24:1317 - 24; http://dx.doi.org/10.1038/leu.2010.90; PMID: 20463750
   PubMed Web of Science ®Google Scholar
• Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41:1350 - 3; http://dx.doi.org/10.1038/ng.471; PMID: 19881528
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178 - 86; http://dx.doi.org/10.1038/ng.298; PMID: 19151715
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al, International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111:5446 - 56; http://dx.doi.org/10.1182/blood-2007-06-093906; PMID: 18216293
   PubMed Web of Science ®Google Scholar